PRESS RELEASE. Sciety portfolio company Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, Inc., a global precision medicine company and an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments. Saga Diagnostics is a
INSIGHT. Traditional medicine has long relied on three pillars: removing, repairing, or replacing damaged tissue. A fourth pillar is now emerging: regenerative medicine. Rather than treating symptoms, regenerative medicine aims to restore the body’s function by stimulating its own healing capacity, potentially reducing the need for prosthetics, transplants, and long-term
PRESS RELEASE. Sciety has led a 36 MSEK funding round in the healthtech company Everdrone. The company operates and develops an autonomous drone service for time-critical medical transport, including the delivery of automated external defibrillators (AEDs) directly to patients in cardiac arrest. Everdrone’s customers include Västra Götaland Region, Region Stockholm
INSIGHT. What trends will shape life science and digital health in the year ahead? Below, we share our insights. 1. Precision medicine reaches everyday clinical practice Personalised treatment has long been a promise, and is now becoming reality. In Sweden, Genomic Medicine Sweden has received SEK 80 million in government
NEWS. Andreas Lindblom, co-founder and Managing Partner at Sciety, features in the latest episode of BioStock’s podcast Health and Wealth – a podcast about investing in life science. In the episode, Andreas shares the strategy that has kept Sciety on a steady growth trajectory through ten years of investing in
PRESS RELEASE. Sciety has led a SEK 87 million financing round for Neogap Therapeutics, a Swedish clinical-stage biotech company developing personalised immunotherapy for cancer. The capital will be used to advance the company’s ongoing Phase I/II clinical trial and build the clinical data required for the next stage of development.